The Digital Apothecary

OCTOBER 4, 2019

Why Digital Health is Key for Pharmacy. And our current pursuits are just not enough. If you have been following my work, you are well aware of my passion and dedication towards getting pharmacists aware of digital health and its implications for future health practice. However, in all honesty, I think I have seen little takeoff amongst the profession by and large, and it has led me to question why that is, so let me break down my current thought process.

Grocery Stores 130

Grocery Stores Independent Pharmacies Community Pharmacies 130

Drug Patent Watch

OCTOBER 24, 2019

DrugPatentWatch can help identify generic entrants at the earliest stages Many clients come to DrugPatentWatch seeking to identify generic entrants well before they launch. CDMOs, equipment manufacturers, regulatory consultants, and…. The post Customer Success: How do we identify generic entrants before they get FDA approval? appeared first on DrugPatentWatch - Make Better Decisions.

105

105

RxNotes

OCTOBER 26, 2019

Drug names, whether brand or generic, are sometimes a pharmacist’s worst enemy. Pronunciation struggles, spelling difficulties, and memorization issues make you wonder how and why pharmaceutical companies come to name their drugs. This is how I assumed drug names were created, but Twitter user Andy Webb (@AJWPharm) started a great thread on drug origin names.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

The Nontraditional Pharmacist

OCTOBER 14, 2019

Kim Tran’s participation with TNP shows how taking advantage of a networking opportunity can lead to making great connections. You never know where a simple conversation will take you! Name : Kim Tran. Position: Pharmacy Student at Oregon State University. Interview Summary. Kim [00:00:00] Hi everyone and this is Kim Tran. I am a PharmD, MBA candidate at Oregon State University and you are listening to The Nontraditional Pharmacist.

Communication 52

Communication Community Pharmacies Pharmaceutical Companies Pharmaceutical Companies 52

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

OCTOBER 30, 2019

Overview Oncology treatment increasingly involves combinations of novel oral and biologic drugs. While combo approaches aren’t new, there are significant cost implications of combining high priced innovator drugs (versus older, generic chemotherapies). Payers are in a difficult spot regarding the cost and management of these regimens. Traditional utilization management tools are still difficult to apply in oncology, given no payer wants to be on the front page of a major newspaper for denying tr

Chemotherapy 40

Chemotherapy 40

Med Ed 101

OCTOBER 30, 2019

In this case scenario below, I discuss the mirabegron tamoxifen interaction and how it can impact patient safety. KS is a 61-year-old female who presents with worsening urinary frequency. She has been diagnosed with overactive bladder and place on oxybutynin. She was taking 5 mg daily and states that the dry mouth from the medication […]. The post Mirabegron Tamoxifen Interaction – Case Scenario appeared first on Med Ed 101.

40

40

RxNotes

OCTOBER 12, 2019

With just under 9 days left until the 2019 Federal Elections, party platforms have been released, important topics have been debated, and election promises have been made. As a pharmacist, the debate on national pharmacare as one of the hot topics of this year’s election campaigns has been intriguing. So where do the major federal … Continue reading ELECTIONS 2019: Where do the four major parties stand on national pharmacare?

52

52

Drug Patent Watch

OCTOBER 29, 2019

This article was originally published by Garth Boehm, Lixin Yao, Liang Hana, and Qiang Zheng in Acta Pharmaceutica Sinica under a creative commons license. Abstract The key events in the…. The post Development of the generic drug industry in the US after the Hatch-Waxman Act of 1984 appeared first on DrugPatentWatch - Make Better Decisions.

53

53

Med Ed 101

OCTOBER 23, 2019

When the NOACs (sometimes referred to as DOACs) first came out they were heavily promoted as having fewer drug interactions compared to warfarin. This is true, but please remember that “fewer drug interactions” doesn’t mean “no drug interactions”! Here’s a scenario of the carbamazepine apixaban interaction and some potential strategies to manage it.

40

40

Med Ed 101

OCTOBER 20, 2019

In an update from a previous post, the CPJE cheating scandal rolls on. Over 1,000 pharmacy students had their scores invalidated. This means that they have to make plans to retake the CPJE exam. In their most recent update on the CPJE cheating scandal, the California Board of Pharmacy has set aside two dates (November […]. The post CPJE Cheating Scandal Update and Free Gift For Those Impacted By This Calamity appeared first on Med Ed 101.

40

40

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Med Ed 101

OCTOBER 16, 2019

As you are reviewing a medication list, it can be easy to overlook supplements. The next time you review a medication list and you see sodium chloride supplements on the list, I want you to think of this post. If you have a patient who needs more sodium, they likely have a problem maintaining a […]. The post Sodium Chloride Supplements – Don’t Overlook Them appeared first on Med Ed 101.

40

40

Med Ed 101

OCTOBER 13, 2019

Our 2020 BCPS Study Material has now been updated and is ready for release!! We’ve reviewed and followed the BCPS content outline closely! If you are considering taking the BCPS exam in the Spring OR Fall of 2020 next year, we’ve done quite a bit of updating! (See below) Here’s some of the feedback we’ve […]. The post 2020 BCPS Study Material Is Ready to Roll!

40

40

Med Ed 101

OCTOBER 9, 2019

We’ve been creating and updating content this fall and getting ready for 2020! Updates will be coming soon as they do every year at this time. BCMTMS (discount ends tomorrow) was just done and BCPS, BCACP, BCGP will be done within the next few weeks! As test time approaches, one of the most frequent questions […]. The post Do I Need to Memorize Labs for the BCPS Exam?

40

40

Med Ed 101

OCTOBER 6, 2019

It is that time of year when we work on updates for our study material and release our All Access Pass for 2020 participants! The BCMTMS certification is something that many pharmacists are pursuing to help improve their resume and their clinical skillset. We are absolutely HONORED to have our study materials mentioned on the […]. The post 2020 BCMTMS Study Material appeared first on Med Ed 101.

40

40

Med Ed 101

OCTOBER 2, 2019

A 68-year-old male presents to your care with chronic back pain. He is taking ketorolac and states that NSAIDs are the mainstay of pain relief. He won’t take opioids due to a family history of addiction. Acetaminophen and other medications he has tried in the past just didn’t do much. He was recently told that […]. The post Strategies to Reduce GI Risk With NSAIDs appeared first on Med Ed 101.

40

40